Silo Pharma Shares Are Trading Higher After the Company Announced Intranasal Delivery of SPC-15 Showed a 'Rapid and Effective' Drug Exposure for PTSD Therapy.
Silo Pharma Shares Are Trading Higher After the Company Announced Intranasal Delivery of SPC-15 Showed a 'Rapid and Effective' Drug Exposure for PTSD Therapy.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.